A review of the phase 4 PALADIN data show that steroid-eluting implants lead to good vision, safe outcomes, and reduced burden in patients with DME.
Daniel F. Kiernan, MD, FACS
Advertisement
Articles by Daniel F. Kiernan, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS
2
Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments
3
Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease
4
Geographic atrophy: When lesion borders cannot be graded
5